News

Major Progress in Next Generation Medicines Initiative

1 week ago

Nottingham, UK – Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reached a key milestone in its work with CrystecPharma and the Advanced Manufacturing Supply Chain Initiative (AMSCI) to create a new platform to accelerate drug development. The contract development and manufacturing organisation (CDMO) now has CrystecPharma’s supercritical fluid technology platform

Webinar – The Importance of Dose Prediction for Early Drug Development

2 months ago

Juniper Pharma Services will be presenting a webinar with Xenogesis: The Importance of Dose Prediction for Early Drug Development at 3.00pm (BST) on Thursday 6th July 2017. The webinar will examine how gaining a thorough understanding of the chemical and pharmacological attributes of a drug substance through preclinical studies is paramount for providing an effective dosage form

Juniper Pharma Services Brings PSD-1 Spray Dryer Online

2 months ago

Nottingham, UK – Juniper Pharma Services (“the company” or “Juniper”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has broadened its manufacturing capabilities bringing on-line its new spray dryer following the successful installation and validation of the advanced manufacturing equipment at its UK-based site. The contract development and manufacturing organisation (CDMO) has seen significant interest

Juniper Pharma Services expands granulation capabilities

10 months ago

Nottingham, UK – Juniper Pharma Services (“the company”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has added a roller compactor to its enabling technologies platform to satisfy increasing market demand for its pharmaceutical development services. The UK-based contract development and manufacturing organisation (CDMO) has purchased a Gerteis MINI-PACTOR® to expand its granulation capabilities and

Webinar – An Integrated Bio-Pharmaceutics Approach For Effective Drug Development

11 months ago

Juniper Pharma Services will be presenting a webinar with Xenogesis: An Integrated Bio-Pharmaceutics Approach for Effective Drug Development at 3.00pm – 4.00pm (BST) on Thursday 8th September 2016. The webinar will examine why new drug candidates fail during development for many reasons, and will be centred around: Undesirable absorption and/or metabolism of the compound in man

Tablet press investment at Juniper Pharma Services

1 year ago

Nottingham, UK – Juniper Pharma Services (“the company”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has bolstered its tablet manufacturing capabilities following the purchase and validation of an additional tablet press. The investment by the UK-based contract development and manufacturing organisation (CDMO) significantly extends its tablet production capacity and further strengthens the company’s ability

Juniper Pharma Services strengthens topicals capability

1 year ago

Nottingham, UK – Juniper Pharma Services (“the company”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reinforced its early stage topical and semi-solids capability by investing in a Becomix homogenizer mixer. The installation and validation of the new equipment extends the company’s ability to manufacture creams, ointments, and semi-solids to support clients’ clinical trial

Juniper Pharma Services scales up spray-drying capability

1 year ago

Nottingham, UK – Juniper Pharma Services (“the company”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reinforced its enabling technologies platform by making a substantial investment into its spray drying capabilities. The contract development and manufacturing organisation (CDMO) has placed an order for a PSD-1 spray dryer, which is manufactured by GEA Niro and

Juniper Pharma Services and XenoGesis to head to Barcelona on market visit

1 year ago

Juniper Pharma Services is joining forces with XenoGesis on a market visit to Barcelona this March. The visit, which is being supported by UKTI, will include a tour of a number of life science companies in the Barcelona area. Juniper Pharma Services and XenoGesis have been working together to offer a seamless and combined service to clients

Juniper and Crystec sign agreement for next generation medicines

2 years ago

Nottingham, UK – Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), will work with CrystecPharma on a major multi-partner project as part of the Advanced Manufacturing Supply Chain Initiative (AMSCI) to help create a new platform to accelerate drug development in the future. Both companies will collaborate as part of this UK-based